haploidentical HSCT
Showing 1 - 25 of 1,167
Hematological Malignancies Trial (Allogeneic T cell progenitors, cultured ex-vivo)
Not yet recruiting
- Hematological Malignancies
- Allogeneic T cell progenitors, cultured ex-vivo
- (no location specified)
Mar 2, 2023
Acute Leukemia Trial in Suzhou (mitoxantrone liposome, ATG)
Recruiting
- Acute Leukemia
- mitoxantrone liposome
- ATG
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Feb 13, 2023
Acute Lymphoblastic Leukemia Trial in Hangzhou (Blinatumomab)
Recruiting
- Acute Lymphoblastic Leukemia
-
Hangzhou, Zhejiang, ChinaThe first affiliated hospital of medical college of zhejiang uni
Nov 5, 2023
Haplo-HSCT for Elderly Acute Leukemia/ Myelodysplastic Syndrome
Not yet recruiting
- Acute Leukemia
- Myelodysplastic Syndromes
-
Beijing, Beijing, ChinaPeking University People's Hospital
Jun 5, 2023
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hodgkin Lymphoma Trial in Madison (TCRaß+/CD19+ depleted Haploidentical
Recruiting
- Acute Myeloid Leukemia
- +10 more
- TCRαβ+/CD19+ depleted Haploidentical HSCT
- Zoledronate
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Mar 1, 2022
Graft-versus-host-disease, Stem Cell Transplant Complications, Acute Myeloid Leukemia Trial in Moscow, Saint Petersburg
Recruiting
- Graft-versus-host-disease
- +3 more
- Ruxolitinib
- +2 more
-
Moscow, Russian Federation
- +1 more
Apr 4, 2022
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Worldwide (biological, drug, procedure)
Terminated
- Acute Myeloid Leukemia
- +2 more
- ATIR101
- +3 more
-
Duarte, California
- +41 more
Apr 28, 2022
Letermovir Prophylaxis for CMV Infection in Haplo-HSCT
Recruiting
- CMV Infection
- Hematopoietic Stem Cell Transplantation
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow university
Mar 29, 2023
To Evaluate the Efficacy and Safety of Secondary Prophylaxis of CMV Reactivation Trial (Letermovir for secondary prophylaxis)
Not yet recruiting
- To Evaluate the Efficacy and Safety of Secondary Prophylaxis of CMV Reactivation
- Letermovir for secondary prophylaxis
- (no location specified)
Jun 13, 2023
Leukemia, Stem Cell Transplant, Cord Blood Trial in Guangzhou (applying of FLU+CY post-HSCT)
Recruiting
- Leukemia
- +2 more
- applying of FLU+CY post-HSCT
-
Guangzhou, Guangdong, ChinaNanfang Hospital
Nov 23, 2023
The Incidence of Peripheral Blood CMV Activation and Confirmed Clinically Significant CMV Infection Within 24 Weeks After
Not yet recruiting
- The Incidence of Peripheral Blood CMV Activation and Confirmed Clinically Significant CMV Infection Within 24 Weeks After Transplantation
- (no location specified)
Jun 13, 2023
Graft-versus-host Disease Trial in New York (Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention)
Active, not recruiting
- Graft-versus-host Disease
- Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention
-
New York, New YorkNYU Langone Health
Aug 5, 2022
Graft Vs Host Disease Trial in New York (Cyclophosphamide, Abatacept, Tacrolimus)
Recruiting
- Graft Vs Host Disease
- Cyclophosphamide
- +2 more
-
New York, New YorkNYU Langone Health
Nov 10, 2022
Leukemia, Graft-versus-host-disease Trial in Hangzhou (Cytarabine, Busulfan, Cyclophosphamide)
Recruiting
- Leukemia
- Graft-versus-host-disease
- Cytarabine
- +9 more
-
Hangzhou, ChinaThe First Affiliated Hospital, College of Medicine, Zhejiang Uni
Dec 25, 2020
High Risk Acute Myeloid Leukemia, Allogeneic Hematopoeitic Stem Cell Transplantation Trial in Shanghai (Cladribine, Fludarabine,
Recruiting
- High Risk Acute Myeloid Leukemia
- Allogeneic Hematopoeitic Stem Cell Transplantation
- Cladribine
- +3 more
-
Shanghai, Shanghai, ChinaShanghai general hospital, Shanghai Jiaotong university school o
Oct 10, 2021
Hematological Malignancies, Hematopoietic Stem Cell Transplantation Trial in Guangzhou (PBSCs, Cord, BMSCs)
Recruiting
- Hematological Malignancies
- Hematopoietic Stem Cell Transplantation
- PBSCs
- +2 more
-
Guangzhou, Guangdong, ChinaDepartment of Hematology,Nanfang Hospital, Southern Medical Univ
Mar 13, 2022
Sickle Cell Disease Trial in Chicago (aß+ T-cell depletion with Miltenyi CliniMACS system)
Recruiting
- Sickle Cell Disease
- αβ+ T-cell depletion with Miltenyi CliniMACS system
-
Chicago, IllinoisThe University of Chicago
May 13, 2022
Lymphoma Trial in Madison (drug, radiation, biological, procedure)
Completed
- Lymphoma
- Fludarabine Phosphate
- +9 more
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Dec 7, 2021
Acute Myeloid Leukemia, MDS Trial in Basel (NK-DLI)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- NK-DLI
-
Basel, SwitzerlandUniversity Hospital Basel
Dec 1, 2020
Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Atlanta (Fludarabine, Melphalan,
Completed
- Chronic Myelogenous Leukemia
- +9 more
- Fludarabine
- +3 more
-
Atlanta, GeorgiaNorthside Hospital
Apr 4, 2022
Primary Immune Deficiency Disorder, Hematopoietic Stem Cell Transplantation Trial in Moscow (Biological: TCR alfa beta T cell
Completed
- Primary Immune Deficiency Disorder
- Hematopoietic Stem Cell Transplantation
- Biological: TCR alfa beta T cell depletion
-
Moscow, Russian FederationDmitry Rogachev Federal Research and Clinical Centre of Paediatr
Feb 9, 2021
Severe Aplastic Anemia Trial in United States (drug, radiation, procedure)
Completed
- Severe Aplastic Anemia
- Antithymocyte Globulin (ATG)
- +7 more
-
Duarte, California
- +27 more
Jul 21, 2022
Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Acute Myeloid Leukaemia Trial in United Kingdom (Reduced intensity haplodentical
Active, not recruiting
- Hodgkin's Lymphoma
- +8 more
- Reduced intensity haplodentical stem cell transplant
- Myeloablative haploidentical stem cell transplant
-
Birmingham, United Kingdom
- +11 more
Sep 27, 2021
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Philadelphia (procedure, drug, radiation)
Recruiting
- Acute Lymphoblastic Leukemia
- +15 more
- Hematopoietic Cell Transplantation
- +7 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Apr 1, 2022